Project Number ADDF-14 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2020 View Full Project Details for MET-FINGER-APOE: A randomized controlled trial of multimodal lifestyle intervention and metformin to prevent cognitive impairment and disability in a cognitively healthy APOE4 enriched at-risk population Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 9. Non-Pharmacological Interventions f. Combination therapy Researcher and Organization Principal Investigator Kivipelto, Miia Principal Investigator First Name MIIA Principal Investigator Last Name KIVIPELTO Awardee Organization Imperial College of London Awardee State England Contact PI Country United Kingdom Project Detail Funding Opportunity Announcement ADDF-Prevention Pipeline Program FY Overall Cost $2,999,865 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management
